All treatments
Treatment
Anti C5 Complement mAb Placebo, Ultomiris 300 mg/30 mL concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
ARTEMIS: RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study
This study looks at a new medicine called Ultomiris to see if it can protect the kidneys of people with existing kidney problems who are having heart surgery. It aims to reduce serious kidney complications after the operation.
For: Prevention of cardiac surgery associated acute kidney injuryItaly · Germany · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants who have Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplant (HSCT)
This study is testing a new medicine called Ultomiris to see if it can help adults who get a serious side effect called TMA after a stem cell transplant. It's comparing Ultomiris to a dummy treatment.
For: Hematopoietic stem cell transplant-associated thrombotic microangiopathyGermany · Poland · France